Impact of diabetes, insulin resistance and cetp inhibition on circulating PCSK9 levels in patients at high cardiovascular risk: The illuminate study. (September 2016) - Arsenault, B.; Tabet, F.; Bao, W.; Petrides, F.; Hovingh, G.K.; Boekholdt, S.M.; DeMicco, D.; Rye, K.A.; Waters, D.; Kastelein, J.; Barter, P.; Lambert, G.